Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00937443 · ClinicalTrials.gov registry record
Effectiveness of a Walking Program Modulating Cardioreparative Factors in Heart Failure
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 9
- Enrollment target
NCT00937443: Completed study, sponsored by Vanderbilt University Medical Center.
NCT00937443 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00937443 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The incidence of heart failure grows as the population continues to age. Heart failure incidence approaches 10 per 1,000 persons after the age of 65. Although pharmacotherapy improves the treatment of heart failure it remains insufficient in preventing the progression of this debilitating disease. Cell based therapy has gained great strides over the last decade, launching cellular therapy into the mix of artillery for the treatment of chronic heart failure and coronary disease. While early pre-clinical work demonstrates that stem cell based therapy improves heart failure the exact mechanism in which these endothelial progenitor cells (EPC's) are recruited from the bone marrow, proliferate under the mediation of growth factors, and migrate to the injured tissues endogenously still remains obscured. Therefore in order for clinicians and scientist to impact heart failure treatment, a greater understanding of the physiological changes in EPC's and other modulators of cardioreparative process need further investigation.
Interventions
- OTHER Physical Fitness
- BIOLOGICAL Walking Exercise Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-01 |
What the finished NCT00937443 record still lists
NCT00937443 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Physical Fitness is the first listed.
NCT00937443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00937443 about?
NCT00937443 is a clinical study titled "Effectiveness of a Walking Program Modulating Cardioreparative Factors in Heart Failure". The incidence of heart failure grows as the population continues to age. Heart failure incidence approaches 10 per 1,000 persons after the age of 65. Although pharmacotherapy improves the treatment of heart failure it remains insufficient in preventing the progression of this debilitating disease. C...
What is the current status of trial NCT00937443?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2009-07. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00937443?
The interventions under investigation include: Physical Fitness (OTHER), Walking Exercise Group (BIOLOGICAL).
Who is sponsoring clinical trial NCT00937443?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia